The Antioxidant, Anti-Inflammatory, and Sedative Effects of Melatonin: Results of Clinical Trials
- 7 Downloads
We present published data (clinical trials and systematic reviews) of the antioxidant and anti-inflammatory effects of melatonin. The results of studies published in recent years on these effects in humans and animals are summarized. Melatonin has been shown to protect the cardiovascular system from damage induced by ischemia/reperfusion when given promptly; it has a neuroprotective effect in neonates after asphyxia; it is an effective agent in the complex treatment of irritable bowel syndrome and inflammatory gut disorders (Crohn’s disease and ulcerative colitis). It is also regarded as a premedication agent, decreasing anxiety for surgery, potentially allowing prescription of benzodiazepines to be avoided.
Keywordsmelatonin ischemia/reperfusion premedication gut diseases
Unable to display preview. Download preview PDF.
- 3.D. L. Carden, and D. N. Granger, “Pathophysiology of ischaemiareperfusion injury,” J. Pathol., 190, 255–266 (2000), https://doi.org/10.1002/(SICI)1096-9896(200002)190:3.CrossRefGoogle Scholar
- 4.K. H. Dwaich, F. G. Y. Al-Amran, B. I. M. Al-Sheibani, and H. A. Al-Aubaidy, “Melatonin effects on myocardial ischemia-reperfusion injury: Impact on the outcome in patients undergoing coronary artery bypass grafting surgery,” Int. J. Cardiol., 221, 977–986 (2016), https://doi.org/10.1016/j.ijcard.2016.07.108.CrossRefGoogle Scholar
- 6.I. Gogenur, B. Kucukakin, L. Panduro Jensen, R. J. Reiter, and J. Rosenberg, “Melatonin reduces cardiac morbidity and markers of myocardial ischemia after elective abdominal aortic aneurism repair: a randomized, placebo-controlled, clinical trial,” J. Pineal Res., 57, 10–15 (2014), https://doi.org/10.1111/jpi.12138.CrossRefGoogle Scholar
- 7.M. G. Poluektov, and S. L. Tsenteradze, “Potential for the use of melatonin in ischemic stroke,” Farmateka, 7, 31–35 (2013).Google Scholar
- 8.E. Ramos, P. Patino, R. J. Reiter, E. Gil-Martin, J. Marco-Contelles, E. Parada, C. Rios, A. Romero, and J. Egea, “Ischemic brain injury: New insights on the protective role of melatonin,” Free Radic. Biol. Med., 104, 32–53 (2017), https://doi.org/ https://doi.org/10.1016/j.freeradbiomed.2017.01.005.
- 9.Ya. Levin, “Melatonin and vascular brain disease,” Russ. Med. Zh., 26, 1732 (2008).Google Scholar
- 10.F. Fulia, E. Gitto, S. Cuzzocrea, R. J. Reiter, L. Dugo, P. Gitto, S. Barberi, S. Cordaro, and I. Barberi, “Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin,” J. Pineal Res., 31, 343–349 (2001), https://doi.org/10.1034/j.1600-079X.2001.310409.x.CrossRefGoogle Scholar
- 11.H. Aly, H. Elmahdy, M. El-Dib, M. Rowisha, M. Awny, T. El- Gohary, M. Elbatch, M. Hamisa, and A. R. El-Mashad, “Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study,” J. Perinatol., 35, 186–191 (2015), https://doi.org/10.1038/jp.2014.186.CrossRefGoogle Scholar
- 15.M. M. Heitkemper, C. J. Han, M. E. Jarrett, H. Gu, D. Djukovic, R. J. Shulman, D. Raftery, W. A. Henderson, and K. C. Cain, “Serum tryptophan metabolite levels during sleep in patients with and without irritable bowel syndrome (IBS),” Biol. Res. Nurs., 18, 193–198 (2016), https://doi.org/10.1177/1099800415594251.CrossRefGoogle Scholar
- 16.M. Storr, P. Koppitz, A. Sibaev, D. Saur, M. Kurjak, H. Franck, V. Schusdziarra, and H. D. Allescher, “Melatonin reduces non-adrenergic, non-cholinergic relaxant neurotransmission by inhibition of nitric oxide synthase activity in the gastrointestinal tract of rodents in vitro,” J. Pineal Res., 33, 101–108 (2002), https://doi.org/10.1034/j.1600-079X.2002.02909.x.CrossRefGoogle Scholar
- 19.A. N. Ananthakrishnan, M. D. Long, C. F. Martin, R. S. Sandler, and M. D. Kappelman, “Sleep disturbance and risk of active disease in patients with Crohn’s disease and ulcerative colitis,” Clin. Gastro-enterol. Hepatol., 11, 965–971 (2013), https://doi.org/10.1016/j.cgh.2013.01.021.CrossRefGoogle Scholar
- 20.P. Boznańska, P. Wichan, A. Stepień, M. Wiśniewska-Jarosńska, J. Smigielski, K. Szadkowski, and K. Stec-Michalska, “24-hour urinary 6-hydroxymelatonin sulfate excretion in patients with ulcerative colitis,” Pol. Merkur. Lek., 22, 369–372 (2007).Google Scholar
- 22.M. Rapoport (ed.), Melatonin: Perspectives for Clinical Utilization, IMA-PRESS., Moscow (2012).Google Scholar
- 24.M. G. Poluektov, “Insomnia,” in: Somnology and Sleep Medicine, M. G. Poluektov (ed.) Medforum, Moscow (2016).Google Scholar
- 25.C. Garzon, J. M. Guerrero, O. Aramburu, and T. Guzman, “Effect of melatonin administration on sleep, behavioral disorders and hypnotic drug discontinuation in the elderly: a randomized, double-blind, placebo-controlled study,” Aging Clin. Exp. Res., 21, 38–42 (2009), https://doi.org/10.1007/BF03324897.CrossRefGoogle Scholar
- 27.A. Wright, J. Diebold, J. Otal, C. Stoneman, J. Wong, C. Wallace, and M. Duffett, “The effect of melatonin on benzodiazepine discontinuation and sleep quality in adults attempting to discontinue benzodiazepines: A systematic review and meta-analysis,” Drugs Aging, 32, 1009–1018 (2015), https://doi.org/10.1007/s40266-015-0322-5.CrossRefGoogle Scholar
- 28.G. H. Guyatt, A. D. Oxman, G. E. Vist, R. Kunz, Y. Falck-Ytter, P. Alonso-Coello, and H. J. Schunemann, “GRADE: An emerging consensus on rating quality of evidence and strength of recommendations,” Chin. J. Evidence-Based Med., 9, 8–11 (2009), https://doi.org/ https://doi.org/10.1136/bmj.39489.470347.AD.
- 29.D. Ionescu, C. Badescu, A. Ilie, I. Miclutia, C. Iancu, D. Ion, H. Vasian, C. Bondor, I. Acalovschi, and T. Mocan, “Melatonin as premedication for laparoscopic cholecystectomy: a double-blind, placebocontrolled study,” South African J. Anaesth. Analg., 14, 8–11 (2008), https://doi.org/10.1080/22201173.2008.10872555.Google Scholar
- 30.M. Karasek, and K. Winczyk, “Melatonin in humans,” J. Physiol. Pharmacol., 57, 19–39 (2006), https://doi.org/https://doi.org/10.1056/NEJM19970 1163360306.Google Scholar
- 31.M. V. Hansen, N. L. Halladin, J. Rosenberg, et al., “Melatonin for pre- and postoperative anxiety in adults,” Cochrane Libr. (2015), https://doi.org/10.1002/14651858.CD009861.pub2.Copyright.
- 32.J. B. Gross, J. L. Apfelbaum, R. A. Caplan, R. T. Connis, C. J. Cote, D. G. Nickinovich, D. S. Ward, E. M. Weawer, and L. Ydens, “Practice guidelines for the perioperative management of patients with obstructive sleep apnea,” Anesthesiology, 120, 268–286 (2014), https://doi.org/10.1097/ALN.0000000000000053.CrossRefGoogle Scholar
- 35.S. R. Lewis, P. Alderson, and A. F. Smith, “Melatonin for the promotion of sleep in the intensive care unit (Protocol),” Cochrane Database Syst. Rev. (2016), https://doi.org/10.1002/14651858.CD012454.